Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check
To secure widespread access to a COVID-19 vaccine, many countries plan to seek refuge in a long-existing strategy: compulsory licensing.
Compulsory License
-
Read more: Compulsory Licensing for Pharmaceuticals in the EU: A Reality Check -
Read more: Big relief for Big Pharma: Indian Patent Office rejects application for compulsory license Big relief for Big Pharma: Indian Patent Office rejects application for compulsory license
By Aditya Gupta By a detailed order passed last week, the Indian Patent Office rejected an application for compulsory license filed by a generic drug manufacturer BDR Pharmaceuticals International Pvt. Ltd. (“BDR”) seeking a license of Bristol Myers Squibb’s (“BMS”) Indian patent for an anti-cancer drug. The Indian Patent Office found that BDR had not made out…